AI Verdict
REGN has stronger fundamentals based on our AI analysis.
CVS vs REGN Fundamental Comparison
| Metric | CVS | REGN |
|---|---|---|
| Revenue | $402.1B | $14.3B |
| Net Income | $1.8B | $4.5B |
| Net Margin | 0.4% | 31.4% |
| ROE | 2.4% | 14.4% |
| ROA | 0.7% | 11.1% |
| Current Ratio | 0.84x | 4.13x |
| Debt/Equity | 0.85x | 0.06x |
| EPS | $1.39 | $41.48 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
CVS vs REGN: Frequently Asked Questions
Is CVS or REGN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), REGN has stronger fundamentals. CVS is rated HOLD (70% confidence) while REGN is rated BUY (80% confidence). This is not investment advice.
How does CVS compare to REGN fundamentally?
CVS HEALTH Corp has ROE of 2.4% vs REGENERON PHARMACEUTICALS, INC.'s 14.4%. Net margins are 0.4% vs 31.4% respectively.
Which stock pays higher dividends, CVS or REGN?
CVS has a dividend yield of N/A or no dividend while REGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in CVS or REGN for long term?
For long-term investing, consider that CVS has HOLD rating with 70% confidence, while REGN has BUY rating with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about CVS vs REGN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For CVS vs REGN, the AI consensus favors REGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.